Skip to main content

Table 2 Zone of inhibition (mm) for the synthesized triphenylamine chalcones and standard controls against test microbes

From: Design, synthesis, docking studies and antibiotic evaluation (in vitro) of some novel (E)-4-(3-(diphenylamino)phenyl)-1-(4-methoxyphenyl)-2-methylbut-3-en-1-one and their analogues

Test organisms

Triphenylamine chalcones

1a

1b

1c

1d

2a

2b

2c

2d

Cip

Flu

E. coli

14

16

15

20

13

18

19

16

30

P. aeruginosa

15

18

18

18

16

18

20

19

40

S. typhi

16

14

17

16

16

13

15

18

26

S. aureus

13

15

14

18

13

13

15

15

28

B. subtilis

16

17

20

17

18

20

20

18

25

MRSA

14

16

19

15

16

17

16

19

30

C. albicans

17

13

20

13

16

20

20

18

20

A. niger

25

30

23

20

20

22

21

23

22

  1. Key; (–): Not determined, Cip ciprofloxacin, Flu fluconazole